Matthew Reynolds to Anti-Retroviral Agents
This is a "connection" page, showing publications Matthew Reynolds has written about Anti-Retroviral Agents.
Connection Strength
0.108
-
Moriarty RV, Harwood OE, Johnson EP, Gardner W, Valencia CC, Conchas A, Immonen TT, Reynolds MR, Keele BF, O'Connor SL. CD8?+ cells suppress SIV replication without the development of mutations within MHC class-I-restricted epitopes during post-treatment control. J Virol. 2026 Jul 21; 100(7):e0004126.
Score: 0.059
-
Harwood OE, Matschke LM, Moriarty RV, Balgeman AJ, Weaver AJ, Ellis-Connell AL, Weiler AM, Winchester LC, Fletcher CV, Friedrich TC, Keele BF, O'Connor DH, Lang JD, Reynolds MR, O'Connor SL. CD8+ cells and small viral reservoirs facilitate post-ART control of SIV replication in M3+ Mauritian cynomolgus macaques initiated on ART two weeks post-infection. PLoS Pathog. 2023 09; 19(9):e1011676.
Score: 0.049